GlassScriptPhysician profile
Daniel Fletcher Byrd
NPI 1295783017
$1,710.85
in general payments reported to CMS, 2019-2025
15 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.37 · 2020: $347 · 2021: $120 · 2022: $543 · 2023: $221 · 2024: $164 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $568.21 | 2020-2024 | Anchorage, Prophecy, Ortholoc 2 Lapifuse |
| Organogenesis INC. | $476.78 | 2020-2025 | Simplimax, Puraply, Novachor |
| Wright Medical Technology, INC. | $246.03 | 2019-2020 | |
| Globus Medical, INC. | $89.41 | 2025 | Senza |
| Smith+Nephew, INC. | $88.10 | 2020-2025 | Grafix Pl |
| Tactile Systems Technology INC | $38.47 | 2022 | |
| Orthofix Medical, INC. | $31.08 | 2020-2022 | |
| Acera Surgical, INC. | $28.62 | 2022 | |
| Horizon Therapeutics Plc | $28.15 | 2019 | |
| Kci USA, INC. | $28.02 | 2019-2023 | Snap, Activ.A.C. |
| Bioventus LLC | $20.46 | 2020 | |
| Integra Lifesciences Corporation | $20.00 | 2021 | |
| Djo, LLC | $17.05 | 2024 | Dr Comfort |
| Nevro Corp. | $16.69 | 2024 | Senza |
| Depuy Synthes Sales INC. | $13.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.